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n INTRODUCTION
Pseudomonas aeruginosa is a Gram-negative op-portunistic bacterium producing severe infec-
tions in weakened patients such those hospital-
ized in intensive care unit (ICU), people suffering 
from cystic fibrosis, AIDS, and burn patients [1]. 
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A wide range of infections including the urinary 
tract infection (UTI), cystic fibrosis, burn wound 
infection, septicemia, and respiratory tract infec-
tions are caused by P. aeruginosa [2]. 
Multi Drug Resistant Pseudomonas aeruginosa 
(MDRPA) is referred to isolates with resistant to at 
least three diverse classes of antibiotics including 
aminoglycosides, carbapenems, antipseudomon-
al penicillins, quinolones, and cephalo sporins [3, 
4]. Infections result from MDR isolates are main 
health care problem for health care systems [5, 6]. 
Owing to intrinsic and acquired resistance of P. 
Biofilm formation is one of the important resistance 
mechanisms in Pseudomonas aeruginosa. This study 
aimed to consider the correlation between biofilm for-
mation and antibiotic resistance in Pseudomonas aerugino-
sa through a systematic review and meta-analysis. This 
study was conducted according to the Preferred Report-
ing Items for Systematic Reviews and Meta-Analyses 
(PRISMA) strategies. Scientific databases were searched 
by MeSH terms and keywords such as “Pseudomonas 
aeruginosa”, “biofilm formation”, “antibiotic resistance”, 
“prevalence” AND “Iran”, to obtain articles published 
from 1st January 2016 to 30th November 2019. Studies 
recording biofilm formation and antibiotic resistance in 
P. aeruginosa recovered from clinical samples of Iranian 
patients were included. Data analysis was performed 
using CMA software. The combined biofilm formation 
rate was reported as 87.6% (95% CI: 80-92.5). The heter-
ogeneity index among the selected articles was Q2=96.5, 
I2=85.5, and t=0.26 (p=0.16). The pooled occurrences of 
SUMMARY
strong, moderate and weak biofilms were 47.7% (95% 
CI: 28.7-67.3), 30.2% (95% CI: 19.4-43.8), and 27.4% (95% 
CI: 8.8-59.8), respectively. The pooled prevalence of 
MDR P. aeruginosa strains was as follows: 62.5% (95% 
CI: 40-77.2). The highest combined rates of antibiotic re-
sistance were against ceftriaxone and tobramycin with 
the rates of 79.2.9% (95% CI: 54.2-96.2) and 64.4% (95% 
CI: 36.3-92), respectively. Also, the lowermost antibiot-
ic resistance rates were against colistin and polymyxin 
B, with the prevalence of 2.1% (95% CI: 0.2-18.1), and 
3% (95% CI: 0.5-17.3), respectively. More than half of the 
studies included in the present review showed a signif-
icant correlation between biofilm formation and antibi-
otic resistance pattern.
Keywords: antibiotic resistance, biofilm formation, cor-
relation, Pseudomonas aeruginosa, meta-analysis.
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aeruginosa against a broad range of antibacterial 
agents, treatment of infections resulted from P. 
aeruginosa is challenging [7, 8]. Infections result-
ing from P. aeruginosa are chiefly challenging due 
to its inherent resistance to many antimicrobial 
agents and its capability of acquiring resistance 
to all effective antibiotics [9, 10]. Regarding the 
limited active antimicrobial agents against MDR 
P. aeruginosa, burden of hospitalization and ther-
apeutic costs are more significant [11, 12]. Sever-
al antibacterial mechanisms include suppression 
of enzyme production, overexpression of efflux 
pumps, and biofilm formation has described for 
resistance of this microorganism that caused con-
cern in clinical settings [13]. 
Biofilm formation is a key strategy used by P. 
aeruginosa to survive in harsh environment such 
as exposure to antibiotics agents and host im-
mune responses [14]. Biofilms are sessile popu-
lations of microorganisms which are enclosed by 
the self-secreted extracellular poly saccharide ma-
trix, or slime. Biofilm are usually more resistant to 
antibiotics in comparison to planktonic cells [15]. 
The National Heart, Lung, and Blood Institute re-
ported that up to 80% of all bacterial infections are 
associated to biofilm formation [16].
Therefore, concerning the noteworthy role of P. 
aeruginosa in nosocomial infection, this study 
aimed to investigate the correlation between bi-
ofilm formation and antibiotic resistance in P. 
aeruginosa through a systematic review and me-
ta-analysis.
n MATERIALS AND METHODS 
This study was conducted following Preferred 
Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) strategies. Scientific 
databases (Web of Science, Cochrane Library, 
Scopus, PubMed, and Google Scholar databas-
es, etc.) searched by MeSH terms and keywords 
such as “Pseudomonas aeruginosa”, “biofilm for-
mation”, “antibiotic resistance”, “prevalence” 
AND “Iran”, were used to get articles published 
from 1th January 2016 and 30th November 2019. 
The studies recording the biofilm formation, 
and the antibiotic resistance in P. aeruginosa re-
covered from clinical samples of Iranian patients 
were selected. The references section of all select-
ed articles was also checked for finding addition-
al studies.
Inclusion criteria 
The cross-sectional studies reporting the biofilm 
formation rate and the antibiotic resistance in P. 
aeruginosa isolated from clinical samples of Irani-
an patients were included. Moreover, only articles 
in which standard microtiter plate test had been 
used for biofilm formation assessment were se-
lected [17]. 
Also, for characterizing the antibiotic resistance 
pattern, only those studies that had used standard 
susceptibility tests such as macrobroth or micro-
broth dilution, or disk diffusion methods based 
on the Clinical & Laboratory Standards Institute 
were included (CLSI) [18].
Exclusion criteria
Letters to editors, reviews (systematic, meta-anal-
ysis, and narrative), editorials, conferences and 
meeting abstracts, case reports, and studies in 
languages other than English were excluded. 
Papers without full text, duplicates, and articles 
with unclear and missing information were not 
considered, too. As well, the two reviewers auton-
omously screened the studies and lastly merged 
their searches. Inconsistencies between them 
were resolved through discussion before settling 
the articles for the next level.
Extraction of data
An information extraction form was used to ex-
tract the related features of each record. These 
data were: the first authors’ names, time of the 
study, biofilm formation rate, the correlation 
between biofilm formation and antibiotic resist-
ance, year of publication, location, sample size, 
and the type of biofilm (i.e. strong, moderate, 
and weak).
Data Analysis 
Data-analysis was done by the Comprehensive 
Meta-Analysis software. The biofilm formation 
was considered with 95% confidence interval 
(CI). Cochrane Q and I2 tests were used for as-
sessing the heterogeneity. In view of the hetero-
geneity, the random-effects model was applied 
to calculate the combined frequencies. Subgroup 
analyses were performed for the type of biofilm, 
and antibiotic resistance pattern. Publication bias 
was checked via Quantitative Egger weighted re-
gression test and Funnel plot. P-value<0.05 was 
considered statistically significant.
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n RESULTS 
Study inclusion criteria and characteristics  
of the eligible studies
A total of 612 studies were recovered, 15 studies 
met our inclusion criteria (Figure 1). 
Generally, as shown in Figure 2 and Table 1, the 
biofilm formation rate varied from 48.5% to 99.5% 
in P. aeruginosa isolates from clinical samples from 
Iranian patients.
Overall effects
The heterogeneity index among the selected arti-
cles were as Q2=96.5, I2=85.5, and t=0.26 (p=0.16). 
Random-effects model was used to pool the fre-
quencies of biofilm formation among the selected 
articles in the current meta-analysis owing to ob-
serving heterogeneity. 
The combined biofilm formation was reported as 
87.6 % (95% CI: 80-92.5), (Table 2). As presented in 
Figure 3, the publication bias was assessed by the 
Funnel plot. Also, Egger’s linear regression test 
was applied to detect any potential publication 
bias and possible asymmetrical data distribution 
in the included articles. But, no publication bias 
was seen regarding Egger’s linear regression test 
(p=0.16). As well, 47.7% (95% CI: 28.7-67.3), 30.2% 
(95% CI: 19.4-43.8), and 27.4% (95% CI: 8.8-59.8) of 
P. aeruginosa isolates were strong, moderate, and 
weak biofilm producers, respectively.
The pooled prevalence of MDR P. aeruginosa 
strains was achieved as 62.5% (95% CI: 40-77.2). 
Figure 1 - Chart of selection 
studies for the present me-
ta-analysis.
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Figure 1 - Chart of selection studies for the present meta-analysis. 322 
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Table 3 showed that the highest combined rates 
of antibiotic resistance were against ceftriaxone 
and tobramycin with the rates of 79.2.9% (95% 
CI: 54.2-96.2), and 64.4% (95% CI: 36.3-92), respec-
tively. Also, the lowermost antibiotic resistance 
rates were against colistin and polymyxin B with 
the prevalence of 2.1% (95% CI: 0.2-18.1), and 3% 
(95% CI: 0.5-17.3), respectively. A correlation was 
seen between biofilm formation and antibiotic 
resistance in 8 out of 15 included articles in the 
current review.
n DISCUSSION 
Biofilm formation has increased antibiotic resist-
ance and leads the use of higher concentrations of 
antibiotics in the treatment of infections caused by 
MDR P. aeruginosa isolates [19]. Overall, the cur-
rent study showed that the biofilm formation rate 
of P. aeruginosa isolates of clinical samples from 
Iranian patients varied from 48.5% to 99.5%. In 
general, the combined ratio of biofilm formation 
was reported as 87.6%. As well, 47.7%, 30.2%, and 
27.4% of P. aeruginosa isolates were strong, mod-
17 
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Figure 2 - Forest plot of the meta-analysis of combined biofilm formation in P. aeruginosa 325 
isolates. 326 
 
Study name Statistics for each study Event rate and 95% CI
Event Lower Upper 
rate limit limit Z-Value p-Value
Azimi 0.869 0.807 0.913 8.072 0.000
Banar 0.965 0.870 0.991 4.604 0.000
Tabatabaei 0.700 0.560 0.810 2.746 0.006
Saffari 0.995 0.920 1.000 3.681 0.000
Valadbeigi 0.667 0.429 0.842 1.386 0.166
Asadpour 0.678 0.575 0.766 3.297 0.001
Dolatabadi 0.990 0.862 0.999 3.247 0.001
Gholamreza zadeh 0.679 0.489 0.824 1.847 0.065
Heydari 0.991 0.875 0.999 3.328 0.001
Karami 0.948 0.852 0.983 4.906 0.000
Nasirmoghadas 0.930 0.860 0.966 6.600 0.000
Pournajaf 0.783 0.708 0.843 6.329 0.000
Satarian 0.485 0.322 0.651 -0.174 0.862
Shokri 0.950 0.874 0.981 5.740 0.000
Bahador 0.987 0.911 0.998 4.275 0.000
0.876 0.800 0.925 6.765 0.000
-1.00 -0.50 0.00 0.50 1.00
Favours A Favours B
Figure 2 - Forest plot of the meta-analysis of combined biofilm formation in P. aeruginosa isolates.
erate, and weak biofilm producers, respectively. 
Accordingly, our findings were in agreement with 
the data published in previous studies where 40-
100% of iso ates were biofilm producers [20, 21]. 
As in a study conducted by Karami et al., 73% of 
both environmental and clinical isolates were bio-
film producers [22]. Also, others reported the high 
biofilm formation that reveals the importance of 
biofilm formation by P. aeruginosa in most in-
fections [23, 24]. In accordance with the present 
results, another study reported that 96.2% of iso-
lates (both MDR, and Non-MDR) of clinical and 
environmental isolates had the ability to create 
the biofilm. The same study reported that 58.6% of 
MDR clinical isolates were producers of strong bi-
ofilm. It showed a significant correlation between 
MDR form and biofilm formation [25]. In contrast 
to the current findings, previous studies from dif-
ferent regions of the world showed a lower prev-
alence of biofilm formation, and consequently no 
association between biofilm producing and anti-
biotic resistance [26-28]. This issue possibly attrib-
uted to other mechanisms (presence of purines, 
plasmid acquisition, chromosomal mutation, and 
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Table 1 - Features of selected articles in the present study.
First 
author 
Time 
of 
study 
Publication
(year)
Location 
Sample 
size 
Biofilm
rate 
Correlation 
between 
biofilm and 
AB resistance
 Biofilm type N (%)
Strong Moderate Weak 
Azimi 
2013-
2014
2016 Tabriz 160
139 
(87%)
No 
110 
(79.13%)
18 
(12.94%)
11(7.91%)
Banar
2013-
2014
2016 Tehran 57
55 
(96.5%)
No 
17 
(30.9%)
26 
(47.3%)
12 
(21.8%)
Tabatabaei – 2017 – 50 35 (70%) Yes 35 (100%) – –
Saffari
2014-
2015
2017 Tehran 92
92 
(99.5%)
Yes – 11 (12%) 81 (88%)
Valadbeigi 2015 2017 Ilam 18
12 
(66.7%)
Yes – – –
Asadpour – 2018 Rasht 90
61 
(67.8%)
Yes
– –
Dolatabadi – 2018 Tehran 50
50 
(99.5%)
No reported
17 
(33.33%)
33 
(66.66%)
–
Gholamreza zadeh 2015 2018 Kerman 28 19 (68%) Yes 8 (42.1%) 7 (36.84%) 4 (21.05%)
Heydari 
2016-
2017
2018 Shiraz 56
56 
(99.5%)
No reported – – –
Karami 
2016-
2017
2018 Hamadan 58
55 
(94.8%)
Yes – – –
Nasirmoghadas 2015 2018 Isfahan 100
93 
(93%)
No 
4 
(4.3%)
22 
(23.65%)
67 
(72.04%)
Pournajaf
2016-
2017
2018 Tehran 143
112 
(78.3%)
No reported
64 
(57.1%)
31 
(27.6%)
17 
(15.2%)
Satarian 
2008-
2009
2018 Tehran 33
16 
(48.5%)
Yes – – –
Shokri
2013-
2014
2018 Isfahan 80 76 (95%) No reported – – –
Bahador 2017 2019
Bandar 
Abbas 
75
74 
(98.7%)
yes
45
(60%)
26 
(34.3%)
3 
(4.3%)
Table 2 - Overall effects of subgroups in P. aeruginosa isolates.
Subgroups
Number 
of studies
Heterogeneity test Egger’s test Random model
Prevalence 
(95% CI) (%)
Z  P Q  P I2 T  P
MDR 7 62.5 (40-77.2) 2.27 0.00 254 0.00 97.1 0.12 0.66
Biofilm 15 87.6 (80-92.5) 6.1 0.00 96.5 0.00 85.5 0.26 0.16
Biofilm types
Strong 8 47.7 (28.7-67.3) 1.11 0.00 201 0.00 92 0.23 0.53
Moderate 8 30.2 (19.4-43.8) 0.13 0.00 77.3 0.00 89.3 0.61 0.34
Weak 7 27.4 (8.8-59.8) 0.23 0.00 178.4 0.00 93.1 0.05 0.11
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Table 3 - Overall effects of antibiotic resistance in P. aeruginosa isolates.
Subgroups
Number 
of studies
 Heterogeneity test  Egger’s test  Random model
Prevalence (95% CI) (%) Z P Q P I2 T P
Imipenem 13 46 (29.3-71.7) 0.32 0.00 219 0.00 94.3 0.13 0.19
Ciprofloxacin 13 51.1 (33.8-65) 0.08 0.00 218 0.00 98.1 0.04 0.56
Gentamicin 12 52.5 (29.9-70.1) 0.56 0.00 320 0.00 90.3 0.7 0.16
Amikacin 14 50 (45-55) 0.36 0.00 289 0.00 99.2 099 0.73
Ceftriaxone 3 79.2.9 (54.2-96.2) 3.4 0.00 34.3 0.00 86.4 1.9 0.001
Ceftazidime 12 57.4 (37.1-78.3) 1.7 0.00 311.8 0.00 87.9 0.06 0.17
Cefepime 6 60.5 (36.4-82.7) 0.36 0.00 0.67 0.00 256 0.76 0.64
Levofloxacin 3 46.9 (7.9-90.6) 0.10 0.00 126.5 0.00 97.6 0.02 0.98
Aztreonam 8 49.4 (33.1-76.3) 0.15 0.00 301 0.00 95.6 2.9 0.08
Piperacillin 7 30.5 (17.9-60.3) 1.8 0.00 134 0.00 88 3.1 0.00
Tobramycin 5 64.4 (36.3-92) 6 0.00 221 0.00 98.2 0.1 0.45
Ticarcillin 2 39 (11-82.9) 0.54 0.00 67.4 0.00 98.4 0.6 2.1
Polymyxin B 4 3 (0.5-17.3) 3 0.00 50 0.00 75 3.6 0.05
Tigecycline 2 6.8 (0. 6-51.5) 4.6 0.00 5.7 0.08 80.1 – –
Colistin 5 2.1 (0.2-18.1) 3.9 0.00 74 0.00 90.9 6 0. 07
Meropenem 7 61.5 (46-82.1) 3.1 0.00 136 0.00 90 0.67 0.61
Piperacillin/
tazobactam
5 47 (16.3-77.8) 5.9 0.00 160 0.00 96 5.1 0.81
18 
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Figure 3 - Funnel plot of meta-analysis on the biofilm formation rate in P. aeruginosa isolated 328 
from Iranian patients. 329 
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Figure 3 - Funnel plot of meta-analysis on the biofilm formation rate in P. aeruginosa isolated from Iranian pa-
tients.
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efflux pumps) involved in resistance against anti-
biotics [29]. 
P. aeruginosa is one of the major microorganisms 
accounting for drug-resistant hospital acquired 
infections [30]. The growing use of antibiotics and 
increasing use of invasive procedures, together 
with the development of intrinsic and acquired re-
sistance mechanisms cause the evolution of MDR 
P. aeruginosa isolates in clinical locations [31]. 
In the present review, the pooled prevalence of 
MDR P. aeruginosa strains was achieved as 62.5%. 
A correlation was seen between biofilm formation 
and antibiotic resistance in more than 50% of in-
cluded studies in the current review. As well, the 
highest combined rates of antibiotic resistance 
were against ceftriaxone and tobramycin with the 
rates of 79.2.9% and 64.4%, respectively. Also, the 
lowermost antibiotic resistance rates were against 
colistin and polymyxin B with the prevalence of 
2.1% and 3%, respectively. 
As all we know, carbapenems are the selective 
choice against MDR isolates; but in a few past 
decades the increasing frequency of P. aeruginosa 
carbapenem-resistant isolates has become a glob-
al concern [32]. Similarly, in our study, the rate of 
resistance against imipenem and meropenem was 
up to 50%, contrary with resistance to colistin and 
polymyxin B.
In the present study the resistance rate against 
colistin was 2%. Accordingly, in 2015, the Euro-
pean Antimicrobial Resistance Surveillance Net-
work (EARS-Net) reported the lowest resistance 
rate (1%-1.1%) against colistin in the United States 
and Europeans hospitals [33, 34]. So, this antibiot-
ic alongside polymyxin B (resistance rate of 3%) is 
the best choice for treating infections caused by P. 
aeruginosa. 
This comprehensive meta-analysis from Iran can 
provide a comprehensive information in this 
area in knowing the antibiotic resistance pattern 
in clinical settings such as hospitals. Surely, this 
information can help us to take preventive meas-
ures.
n CONCLUSION 
In summary, this study reports a significant cor-
relation between biofilm formation and antibiotic 
resistance. Antimicrobial resistance in P. aerugino-
sa is increasing worldwide. Therefore, it is sug-
gested to use of alternative antimicrobial com-
pounds such as plant extracts in combination with 
antibiotics or alone to increase the effectiveness of 
drugs by creating synergistic effects against MDR 
P. aeruginosa isolates.
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